Conference & Events
Event Details
Late Phase Drug Development World Europe 2009
The first ever strategic conference addressing the major challenges in conducting strategic and compliant late stage studies.
Date: 01 December 2009 08:00 - 04 December 2009 17:00
Event Subject(s):
Biosciences
Venue
The Bloomsbury Hotel
London
United Kingdom
Organiser Information
Organiser(s): Health Network Communications
Contact for Event Information
Name : Miss Julie Phillips
Address:
Welken House
10-11 Charterhouse Square
london
EC1M 6EH
United Kingdom
Tel:
+44 (0) 207 608 7039
Fax:
+44 (0) 207 608 7050
Email:
jphillips@healthnetworkcommunications.com
Contact Useful link:
http://www.healthnetworkcommunications.com
Additional Information
Speaker Information:
http://www.healthnetworkcommunications.com/2009/LSDD/speakerList.stm
Booking form or other file(s):
Brochure_Late Phase screen.pdf
Useful link:
http://www.healthnetworkcommunications.com/2009/lsdd
Other information:
Late stage drug development is growing at around 20% annually, exceeding the growth rate of Phase II and III Trials. In excess of $12 billion is currently being spent on Phase IIIb/IV studies as public concerns on the safety of approved drugs prevail together with the need to evaluate real world safety and effectiveness of marketed drugs. More than ever before there is the urgent need to detect, quantify and communicate patient risk with speed and efficiency. As a result, Health Network Communications is delighted to announce the first ever strategic forum addressing the major challenges in conducting strategic and compliant late stage studies.
